Today's Healthcare Pulse
Abridge teams with Eli Lilly and Nvidia to expand AI scribe platform
Abridge announced a strategic investment from Eli Lilly and a partnership with Nvidia to build a foundation model for clinical conversations. The AI‑scribe provider now serves over 300 health systems and plans to integrate its platform with payers and broader care settings.
Also developing:
By the numbers: Kardigan targets $1.4B IPO valuation
Patients Are Using AI For Medical Advice. Here’s How To Do It Safely.
A Gallup poll shows 16 % of U.S. adults now rely on consumer AI chatbots for medical advice, highlighting a shift in patient behavior. These tools can simplify medical language and help patients prepare for visits, but they lack HIPAA compliance and may retain sensitive data for model training. Experts outline five guardrails—limiting data shared, demanding reputable citations, restricting use to translation, avoiding anxiety‑driven rabbit holes, and choosing privacy‑aware platforms. Following these steps lets patients benefit from AI while protecting safety and privacy.
2026 Star Ratings Shift: 4 Strategies for MA Plans
CMS has unveiled a sweeping overhaul of the Medicare Advantage Star Ratings, targeting the 2028 and 2029 rating cycles. The agency will drop 12 administrative and two clinical measures, eliminate the Health Equity Index incentive, and introduce a depression‑screening metric....
How AI Is Transforming Detection of Congenital Heart Defects
AI‑enabled ultrasound is emerging as a tool to improve prenatal detection of congenital heart defects (CHDs), which affect about 1 % of U.S. births and are frequently missed. FDA‑cleared AI platforms can analyze cardiac images in real time, flagging abnormal views...
Big Tech Accelerates Into Healthcare With Partnerships
Big tech companies like Amazon, Google/Alphabet, Apple, NVIDIA and Microsoft are taking their move into healthcare and medicine seriously. They are developing new, health-related features on their platforms. They are also teaming up with research institutions and developers to create new...
FDA Picks Radiologist to Fill Key AI-Related Role
The FDA has appointed Dr. Jeffrey Abramson, a veteran radiologist with extensive AI and health‑policy experience, to a senior role within its Digital Health Center of Excellence. The move comes as the agency shifts toward a more hands‑off regulatory stance...
MedisourceRx - 717970 - 12/12/2025
The FDA issued a warning letter to MedisourceRx after an inspection found the facility’s compounded sterile drugs failed to meet 503B outsourcing‑facility requirements. Specific violations include marketing unapproved new drugs, misbranding due to inadequate labeling, and inadequate adverse‑event reporting. The...
Medi-Globe Launches mAI Companion AI Assistant for Pancreatic EUS
Medical device maker Medi‑Globe has launched mAI Companion, a CE‑marked real‑time AI assistant for pancreatic endoscopic ultrasound (EUS). Developed with IHU Strasbourg, the system analyses the pancreas during procedures to highlight solid and cystic lesions, acting as a second set...
Medical AI Is Already In Hospitals. Who Is Watching Its Safety?
The FDA has opened public comment on a citizen petition that would shift oversight of adaptive radiology AI tools from repeated pre‑market reviews to continuous post‑market monitoring. As AI algorithms are updated to improve performance or expand indications, the traditional...
How Camunda’s Skyflow Connector Helps Regulated Organizations Orchestrate Sensitive Data Safely
Camunda introduced a Skyflow connector that tokenizes and de‑identifies PII/PHI within BPMN workflows. The connector forwards selected fields to Skyflow’s vault, replaces them with tokens, and permits controlled re‑identification only at approved steps. This approach shrinks the cleartext data footprint...
Pfizer’s Strategy: How the Company Is Evolving After Its COVID Success
Pfizer’s post‑COVID strategy pivots from vaccine and antiviral sales to rebuilding growth through oncology and metabolic assets. The 2026 guidance excludes COVID revenue, projects modest 4% operational growth, and anticipates a $1.5 billion patent‑cliff hit. To offset these pressures, Pfizer completed...
Successful Readout of Prospective Phase 2 SINERGY Trial Supports SignateraTM MRD-Guided Treatment in Head and Neck Cancer
Natera reported Phase 2 SINERGY trial results showing a 63% objective response rate in recurrent or metastatic head and neck squamous cell carcinoma when treatment was adapted using Signatera circulating tumor DNA monitoring. Seventy‑four percent of the 27 patients were de‑escalated...
Oxford University Hospitals Shares Evaluation of Ambient Voice Pilots
Oxford University Hospitals (OUH) NHS Foundation Trust completed a pilot of ambient voice technology (AVT) across inpatient and outpatient settings, testing four vendors – Accurx Scribe, Tortus, Heidi and Lyrebird. Almost 90% of clinicians reported reduced documentation time, with 88%...
Some Patients Listed as “Charlie Kirk” Or Dead After Major NZ Health App MediMap Hacked
New Zealand health‑tech firm MediMap was forced offline after an unauthorized intrusion altered patient records, including changing names to “Charlie Kirk” and marking individuals as deceased. The breach affected dozens of providers in aged‑care, disability, hospice and community settings, prompting the...
€1m Digital Mental Health Strategy for Ireland
Ireland has unveiled a €1 million digital mental health strategy that outlines a national roadmap for digital tools, shared records and technology‑enabled services. The plan builds on the 2020‑2030 "Sharing the Vision" policy and prioritises the HSE Health App, a national...
Canary Speech, JubileeTV Partner on AI Voice Biomarkers for At-Home Care
Canary Speech has partnered with JubileeTV to embed its AI‑driven vocal‑biomarker technology into consumer video calls, marking the first deployment outside clinical settings. The system analyzes 40 seconds of natural conversation, extracting thousands of acoustic features to generate nondiagnostic scores...
TigerConnect Aims to Use AI to Modernize Hospital Operator, Management Systems
TigerConnect unveiled a cloud‑native operator console aimed at replacing decades‑old hospital switchboards. The platform unifies call routing, code activations, and alarm management into a single dashboard while integrating with EHRs, telephony and scheduling tools. AI‑driven automation and intelligent search streamline...
Untitled
At a recent round‑table, a speaker outlined how the NHS 10‑year plan can be accelerated by applying platform‑centric principles drawn from the Platformland framework. The presentation highlighted four pillars: digital ways of working, platform‑based clinical functions, converting the public into...
Switching to Syai CGM for Easier Glucose Monitoring
I just started testing a new continuous glucose monitor (CGM) device from Syai. I tried Abbott Freestyle Libre 2 and Sibionics before, but the need for the reader with Libre was a pain in the process, and the Sibionics app is...
Texas V. Epic: Market Definition and Whataburger Edition
Texas filed its antitrust suit against Epic Systems in state court to avoid federal consolidation and the stricter Twombly/Iqbal pleading standards. Epic’s motion to dismiss challenges the state’s market definition, arguing that the split between acute‑care and academic hospital EHR...
Kyndryl and University of Liverpool to Spearhead Health Innovation with Agentic AI
Kyndryl and the University of Liverpool’s Civic Health Innovation Labs have launched a partnership to apply Kyndryl’s Agentic AI Framework to co‑develop blueprints for next‑generation healthcare technologies. The first phase will generate conceptual AI projects, emphasizing conversational agents that help...
Why Maintenance of Certification Varies Widely: A System in Crisis
Maintenance of certification (MOC) for physicians varies dramatically across specialties and states, creating a fragmented, costly system with little evidence of patient‑outcome benefits. Boards under the ABMS set broad standards but allow autonomous, disparate requirements ranging from quarterly quizzes to...
Sciwind Biosciences and Pfizer China Partner to Commercialize Ecnoglutide in China
Sciwind Biosciences granted Pfizer China exclusive rights to commercialize ecnoglutide injection in Mainland China. Sciwind will keep the marketing authorization and handle R&D, registration, manufacturing, and supply, receiving up to $495 million in milestone payments. Ecnoglutide, a cAMP‑biased GLP‑1 receptor agonist,...
There’s a Silver Lining to Our Health Care Cost Crisis
Congress missed its Jan. 30 deadline to extend ACA subsidies, leaving roughly four million Americans without financial assistance and prompting a surge in uninsured individuals. The lapse underscores a broader health‑care cost crisis that has become a flashpoint ahead of the...
Camel Antimicrobials Could Get Us over the Hump of Antibiotic Resistance
Researchers at Sultan Qaboos University have isolated three antimicrobial peptides from dromedary camels, with CdPG-3 and CdCATH showing potent activity against methicillin‑resistant Staphylococcus aureus and multidrug‑resistant Escherichia coli. The peptides kill bacteria by disrupting their membranes while exhibiting low toxicity...
No Time to Heal: The Psychological Rehabilitation of a Ukrainian Soldier After Russian Captivity
The Guardian profiles Ukraine’s first psychological trauma centre, Forest Glade, where soldiers like 25‑year‑old Kyrylo Chuvak undergo intensive three‑week rehabilitation after years of Russian captivity. The programme blends conventional therapy with unconventional activities such as tango, archery and guided breathing to...
Does Living Near A Nuclear Plant Increase Deaths From Cancer?
A Harvard study published in Nature Communications reports that U.S. residents living closer to operational nuclear power plants face higher cancer mortality rates. The analysis covered mortality data from every county between 2000 and 2018 and adjusted for smoking, BMI,...
MiraDx Launches New PROSTOX Genetic Test for Prostate Cancer Patients
MiraDx has launched PROSTOX Standard, a clinically validated genetic test that predicts long‑term urinary toxicity for prostate cancer patients receiving conventional or moderately hypofractionated radiation therapy. The test uses a cheek swab and returns results in five to seven days,...
North Korean Lazarus Group Linked to Medusa Ransomware Attacks
North Korean state‑backed Lazarus group has been linked to recent Medusa ransomware attacks targeting U.S. healthcare providers. Symantec’s report identifies a Lazarus sub‑unit, possibly Andariel/Stonefly, using the Medusa RaaS platform, which has affected more than 380 organizations since its 2021...
Revealing the Structural Fingerprints of Disease: Q&A with Faraz Choudhury
Immuto’s CEO Faraz Choudhury explains that conventional target discovery, which focuses on gene mutations and protein abundance, overlooks disease‑specific protein conformations. The company’s platform maps surface protein conformations (SPCs) in living, patient‑derived models using high‑resolution mass spectrometry and AI‑driven analysis,...
FDA Grants Breakthrough Designation to Orthonika’s Synthetic Total Meniscus Implant
Orthonika, an Imperial College London spin‑out, received FDA Breakthrough Device Designation for its synthetic Total Meniscus Replacement (TMR) implant and an invitation to the Total Product Life Cycle Advisory Program. The designation promises prioritized regulatory engagement, speeding the path to...
FDA Accepts Beren Therapeutics’ NDA for Niemann-Pick Disease
Beren Therapeutics announced that the U.S. Food and Drug Administration has accepted its New Drug Application for adrabetadex, an investigational therapy aimed at treating infantile‑onset Niemann‑Pick disease type C (NPC). The agency set a target action date of 17 August 2026 under the...
Swallowable Robots Promise Safer, Remote Diagnostics
The future of medicine might be something you swallow. When I first read about PillBot, I paused. A tiny ingestible robot camera that replaces traditional endoscopies? That is not incremental innovation. That is a shift. Instead of invasive tubes and hospital procedures,...
FDA Draft Guidance Boosts Individualized Therapy Innovation
FDA Issues Plausible Mechanism Pathway Draft Guidance to Spur Innovation for Individualized Therapies https://t.co/OZW6Q27zMa via @Inside_PM
Epredia and Mindpeak Announce EU Distribution Agreement for AI-Powered Image Recognition in Cancer Diagnostics
Epredia and Mindpeak have signed a distribution agreement to bring Mindpeak’s AI‑driven image‑recognition software to Epredia’s European digital pathology customers. The AI modules deliver pixel‑level analysis for breast, lung, gastrointestinal cancers and biomarker quantification, operating without cloud connectivity to preserve...
AI-Driven Care Models Enhance Long-Term Cancer Survivors' Quality
As more patients live years—sometimes decades—beyond a cancer diagnosis, we need smarter, sustainable care models focused on improving quality of life. At @Oracle, we're use AI and real-world evidence to advance smarter, more equitable cancer care: https://t.co/h28j1sIrN3
Budapest’s Turbine Secures $25M to Simulate Lab Experiments
The latest AI biotech raise comes not from the Bay Area or Boston, but out of Budapest Turbine has closed a $25M Series B, planning to build AI models that can simulate more and more lab experiments: https://t.co/Q31DVENA9G
STAT+: New Treatment Approach Could Give IBD Patients Hope, and Be a Bonanza for Drugmakers
A new combination‑therapy approach for inflammatory bowel disease (IBD) aims to boost remission rates beyond the current 30 % success benchmark. By pairing agents that target distinct immune pathways, early trials show remission climbing to roughly 55 % and faster mucosal healing....
Slate Secures $130M, Launches Chinese Headache Drug
Slate starts up with $130M and a headache drug from China https://t.co/6DEltQAI8s by @gwendolynawu #biotech #startups $HLUBF
Advancing Pediatric MASLD Screening: Challenges and Future
A forthcoming Pediatric Research review by Vimalesvaran and Dhawan examines the current state of Metabolic Dysfunction‑associated Steatotic Liver Disease (MASLD) screening in children, highlighting advances in imaging and biomarker research while exposing persistent gaps in sensitivity and guideline standardization. The...
GSMA Foundry and NUHS Singapore to Drive 5G and AI Innovations in Healthcare Through New Strategic Partnership
GSMA Foundry has signed a strategic partnership with Singapore’s National University Health System (NUHS) to accelerate 5G‑enabled, AI‑driven healthcare solutions. The collaboration will leverage private 5G networks, digital twins, XR, IoT and ambient AI to enable remote surgical assistance, immersive...
Comparing Senescence in Articular Chondrocytes: Phenotype & Molecules
Researchers published a comparative analysis of replicative versus chemically‑induced senescence in articular chondrocytes, revealing divergent molecular signatures, secretory profiles, and mitochondrial dynamics. Replicative senescence displayed a controlled, anti‑inflammatory SASP and stable epigenetic marks, while chemically‑induced senescence produced a pro‑inflammatory secretome,...
b.well Connected Health Unveils Bailey™
b.well Connected Health launched bailey™, a white‑label AI health assistant that can be embedded into an organization’s existing apps in weeks. Powered by b.well’s Health AI SDK and a 13‑step data refinery, bailey accesses a longitudinal health record compiled from...
Where MENA CIOs Draw the Line on AI Sovereignty
MENA CIOs are drawing firm lines around AI sovereignty, keeping regulated workloads—such as patient data, identity systems, and core financial transactions—on sovereign or on‑premise infrastructure while leveraging hyperscalers for development, testing, and non‑sensitive analytics. The hybrid approach reflects regional regulatory...
New Research Reveals Dry Powder Inhalers Enhance Patient Outcomes and Reduce Environmental Impact
UCLA Health researchers published a JAMA Internal Medicine study showing that dry powder inhalers (DPIs) and soft‑mist inhalers (SMIs) cut COPD exacerbations while eliminating high‑global‑warming‑potential propellants used in metered‑dose inhalers (MDIs). The analysis of insurance‑claims data from 2016‑2025 found a...
Hims Reports 2025 Earnings, Shares Details on GLP-1 Pill Decisions
Hims & Hers disclosed its fourth‑quarter earnings and announced that it has withdrawn the controversial GLP‑1 weight‑loss pill it briefly launched. The decision followed conversations with key ecosystem stakeholders, including regulators and partner pharmacies. The company highlighted modest revenue growth...
InnoScot Issues Call for Early-Stage Innovations Around Patient Care, Efficiency, Workforce, and Transformation
InnoScot Health has launched a call for early‑stage innovators—including final‑year trainees, first‑year practitioners, SMEs and student entrepreneurs—to submit ideas that improve patient care, efficiency, workforce wellbeing, or enable data‑driven remote care. Successful applicants will receive a support package covering intellectual‑property...
FDA Approves Allurion’s PMA Application for Gastric Balloon System
Allurion received FDA clearance for its Gastric Balloon System featuring the Smart Capsule, a swallow‑able, endoscopy‑free obesity treatment. The capsule is placed during a 15‑minute office visit, inflates in the stomach for about four months, then exits naturally, with a...
Combining Soft and Hard Properties: Synergistic Innovation of Magnetic Hydrogel Microrobots in Precision Medicine
Magnetic hydrogel microrobots (MHMs) are emerging untethered soft robots that combine magnetic actuation with responsive hydrogel matrices. Recent research highlights dual design strategies that integrate material optimization and functional integration, enabling precise, spatiotemporal control. Innovations in bionic structures and multimodal...
CMS Updates MIPS for 2026: Administrative Claims, TEFCA Bonuses, and AI Safety Measures
CMS released its 2026 Merit‑based Incentive Payment System updates, adding administrative claims scoring, a TEFCA participation bonus, and a new AI safety measure. The changes affect quality, interoperability, improvement activities, and cost categories, with retroactive application to 2025 for large...
Assessing Targeted HIV and Harm Reduction Services
A new NIH‑backed assessment of targeted HIV prevention and harm‑reduction services in five major U.S. cities shows a 15% decline in new infections over the past year. The study attributes the drop to expanded syringe‑exchange programs, mobile testing units, and...